ARGENX

Welcome to the Brand page for “ARGENX”, which is offered here for The mark consists of the word argenx in lowercase in dark gray followed by a v-shaped design, the left segment in dark green and the right segment in green, positioned above a circle in green.;pharmaceuticals and medical preparations in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system;the color(s) dark gray, green, dark green is/are claimed as a feature of the mark.;wholesale and retail services for pharmaceutical preparations in the field of immunology and autoimmune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; marketing and patient information services in the field of immunology, diseases of the immune system and antibody therapeutics; provision of customer or patient information on pharmaceutical, medical, healthcare products through an online computer network; administration of patient reimbursement programs;providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to biopharmaceutical products;research and development in the field of immunology, antibody engineering and autoimmune diseases; drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering; providing medical and scientific research information in the field of pharmaceuticals, clinical trials, research and development;.

Its status is currently believed to be active. Its class is unavailable. “ARGENX” is believed to be currently owned by “Argenx B.V.”